These symptoms are primarily due to the mode of action of GLP-1 RAs on the gut, as a GLP-1 may directly or indirectly regulate electrolyte and fluid homeostasis by influencing feeding and drinking behavior as well as electrolyte transport in the kidneys and gastrointestinal tract [25]
However, no head-to-head comparisons of GLP-1RAs and other non-insulin glucose-lowering medications exist for patients with NAFLD and type 2 diabetes
Heres a closer look at the four major GLP-1 drugs on the market (Ozempic, Mounjaro, Wegovy, and Zepbound): Of these medications, only Zepbound (known generically as tirzepatide) is FDA-approved to treat sleep apnea in those with a body mass index (BMI) of 30 or higher
Before imputation, variants were filtered by call rate 5% missingness
Part B still doesnt cover outpatient prescription drugs for obesity
Calculating the Correct Volume To figure out the right mL volume, we look at the solutions concentration